The transcriptional regulation of c-fos will be studied as a method towards understanding the signal transduction pathways of the cell. Transcription of the c-fos is induced rapidly by growth factors and other agents that affect cell growth and differentiation. Growth factors bind to their receptors on the cell surface, yet most of he subsequent biochemical steps that lead to increased c-fos expression and ultimately cell division are not understood. Incorrect c-fos expression can cause the cancerous transformation of cells and aberrant control of the signal transduction pathways may also lead to oncogenesis. Thus, a detailed analysis of these pathways is crucial to the understanding and treatment of cancer. The key element in the c-fos promoter for serum and epidermal growth factor regulation is the serum response element (SRE). the regulation is likely to be mediated by the serum response factor (SRF) which binds specifically to SRE. Three approaches will be used analyze regulation through SRF. 1) Phosphorylation of SRF as a regulatory modification will be investigated. Since c-fos expression is induced in the presence of protein synthesis inhibitors, post-translational modifications must be involved in the regulation. SRF is phosphorylated in vivo and this modification is required for the DNA binding activity in vitro. 2) In vitro transcription systems with crude and purified components will be utilized to assay for changes n SRF's transcriptional activity. This activity appears to be regulated separately from its DNA binding activity. 3) SRF may be regulated positively or negatively by proteins which complex with it. Such proteins which stably bind to SRF will be sought by their copurification or co-immunoprecipitation with SRF. Changes in cellular calcium levels may play an important part in growth regulation. Calcium regulation of c-fos is independent of SRE and appears to utilize sequence elements downstream of the cap site. The calcium response element(s) will be mapped, nuclear factor(s) which bind to it will be identified, and the biochemical mechanism of regulation through these sequence elements and factors will be investigated.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA050329-03
Application #
3194735
Study Section
Molecular Biology Study Section (MBY)
Project Start
1989-07-01
Project End
1993-06-30
Budget Start
1991-07-01
Budget End
1993-06-30
Support Year
3
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
Other Domestic Higher Education
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10027
Lewis, Thera C; Prywes, Ron (2013) Serum regulation of Id1 expression by a BMP pathway and BMP responsive element. Biochim Biophys Acta 1829:1147-59
Muehlich, S; Hampl, V; Khalid, S et al. (2012) The transcriptional coactivators megakaryoblastic leukemia 1/2 mediate the effects of loss of the tumor suppressor deleted in liver cancer 1. Oncogene 31:3913-23
Lee, Seung-Min; Vasishtha, Mansi; Prywes, Ron (2010) Activation and repression of cellular immediate early genes by serum response factor cofactors. J Biol Chem 285:22036-49
Muehlich, Susanne; Wang, Ruigong; Lee, Seung-Min et al. (2008) Serum-induced phosphorylation of the serum response factor coactivator MKL1 by the extracellular signal-regulated kinase 1/2 pathway inhibits its nuclear localization. Mol Cell Biol 28:6302-13
Shen, Jingshi; Snapp, Erik L; Lippincott-Schwartz, Jennifer et al. (2005) Stable binding of ATF6 to BiP in the endoplasmic reticulum stress response. Mol Cell Biol 25:921-32
Selvaraj, Ahalya; Prywes, Ron (2004) Expression profiling of serum inducible genes identifies a subset of SRF target genes that are MKL dependent. BMC Mol Biol 5:13
Shen, Jingshi; Prywes, Ron (2004) Dependence of site-2 protease cleavage of ATF6 on prior site-1 protease digestion is determined by the size of the luminal domain of ATF6. J Biol Chem 279:43046-51
Selvaraj, Ahalya; Prywes, Ron (2003) Megakaryoblastic leukemia-1/2, a transcriptional co-activator of serum response factor, is required for skeletal myogenic differentiation. J Biol Chem 278:41977-87
Cen, Bo; Selvaraj, Ahalya; Burgess, Rebecca C et al. (2003) Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes. Mol Cell Biol 23:6597-608
Gupta, Pankaj; Prywes, Ron (2002) ATF1 phosphorylation by the ERK MAPK pathway is required for epidermal growth factor-induced c-jun expression. J Biol Chem 277:50550-6

Showing the most recent 10 out of 30 publications